Scancell Holdings plc (AIM:SCLP)
London · Delayed Price · Currency is GBP · Price in GBX 11.56
+0.31 (2.76%)
Mar 25, 2026, 3:43 PM GMT
Scancell Holdings Market Cap
Scancell Holdings has a market cap or net worth of 121.94 million as of March 25, 2026. Its market cap has increased by 42.16% in one year.
Market Cap
121.94M
Enterprise Value
129.55M
Revenue
4.71M
Ranking
n/a
PE Ratio
n/a
Stock Price
11.56
Market Cap Chart
Since June 29, 2009, Scancell Holdings's market cap has increased from 3.13M to 121.94M, an increase of 3,790.80%. That is a compound annual growth rate of 24.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 24, 2026 | 116.75M | 13.64% |
| Dec 31, 2025 | 102.74M | -6.96% |
| Dec 31, 2024 | 110.43M | 28.31% |
| Dec 29, 2023 | 86.06M | -57.34% |
| Dec 30, 2022 | 201.77M | 23.75% |
| Dec 31, 2021 | 163.04M | 42.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Avacta Group | 301.81M |
| PureTech Health | 280.99M |
| 4basebio | 80.48M |
| Bioventix | 75.76M |
| Hemogenyx Pharmaceuticals | 58.86M |
| Ondine Biomedical | 55.85M |
| Faron Pharmaceuticals Oy | 51.52M |
| hVIVO | 46.95M |